Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
Document Type
Article
Publication Date
3-2024
Publication Title
The Journal of urology
Volume
211
Issue
3
First Page
482
Last Page
482
Recommended Citation
Garnick MB, Hafron J, Crawford ED. Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist. J Urol. 2024 Mar;211(3):482. doi: 10.1097/JU.0000000000003831. PMID: 38179977.
DOI
10.1097/JU.0000000000003831
ISSN
1527-3792
PubMed ID
38179977
COinS